TUB-040 targets the sodium-dependent phosphate transport protein 2B (NaPi2b), commonly overexpressed in ovarian cancer and ...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round ...

When doctors told the father of two his cancer was seen just three times a year in Oregon, he found a lifeline 2,000 miles ...

Uterine cancer symptoms include irregular bleeding and pelvic pain, but early diagnosis through medical evaluation can lead ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral ...

Data from the Phase 1 trial of ZW191 provide readthrough to Zymeworks’ broader ADC portfolio utilizing its novel bystander active topoisomerase-1 inhibitor payload, ZD06519.

Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian cancer HOLON, Israel, Oct. 13, ...

"I began running again, and it helped me reclaim my independence and gave me back a sense of achievement that cancer temporarily took away." Ms Jordan said she would look at the race on Sunday as a ...

Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Eli Lilly and Company is conducting a two-part Phase 3 study ...